Abstract
Regulated cell death (RCD) pathways, such as pyroptosis, apoptosis, and necroptosis, are essential for maintaining the body’s balance, defending against pathogens, and eliminating abnormal cells that could lead to diseases like cancer. Although these pathways operate through distinct mechanisms, recent genetic and pharmacological studies have shown that they can interact and influence each other. The concept of “PANoptosis” has emerged, highlighting the interplay between pyroptosis, apoptosis, and necroptosis, especially during cellular responses to infections. This article provides a concise overview of PANoptosis and its molecular mechanisms, exploring its implications in various diseases. The review focuses on the extensive interactions among different RCD pathways, emphasizing the role of PANoptosis in infections, cytokine storms, inflammatory diseases, and cancer. Understanding PANoptosis is crucial for develo** novel treatments for conditions involving infections, sterile inflammations, and cancer.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12272-024-01506-0/MediaObjects/12272_2024_1506_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12272-024-01506-0/MediaObjects/12272_2024_1506_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12272-024-01506-0/MediaObjects/12272_2024_1506_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12272-024-01506-0/MediaObjects/12272_2024_1506_Fig4_HTML.png)
Data availability
This paper is a review paper and does not contain any data.
References
Banoth B, Tuladhar S, Karki R, Sharma BR, Briard B, Kesavardhana S, Burton A, Kanneganti TD (2020) ZBP1 promotes fungi-induced inflammasome activation and pyroptosis, apoptosis, and necroptosis (PANoptosis). J Biol Chem 295:18276–18283. https://doi.org/10.1074/jbc.RA120.015924
Byun JK (2023) Tumor lactic acid: a potential target for cancer therapy. Arch Pharm Res 46:90–110. https://doi.org/10.1007/s12272-023-01431-8
Cai Z, Jitkaew S, Zhao J, Chiang HC, Choksi S, Liu J, Ward Y, Wu LG, Liu ZG (2014) Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol 16:55–65. https://doi.org/10.1038/ncb2883
Cecconi F (1999) Apaf1 and the apoptotic machinery. Cell Death Differ 6:1087–1098. https://doi.org/10.1038/sj.cdd.4400602
Chipuk JE, Bouchier-Hayes L, Green DR (2006) Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario. Cell Death Differ 13:1396–1402. https://doi.org/10.1038/sj.cdd.4401963
Chitu V, Ferguson PJ, De Bruijn R, Schlueter AJ, Ochoa LA, Waldschmidt TJ, Yeung YG, Stanley ER (2009) Primed innate immunity leads to autoinflammatory disease in PSTPIP2-deficient cmo mice. Blood 114:2497–2505. https://doi.org/10.1182/blood-2009-02-204925
Christgen S, Kanneganti TD (2020) Inflammasomes and the fine line between defense and disease. Curr Opin Immunol 62:39–44. https://doi.org/10.1016/j.coi.2019.11.007
Christgen S, Zheng M, Kesavardhana S, Karki R, Malireddi RKS, Banoth B, Place DE, Briard B, Sharma BR, Tuladhar S, Samir P, Burton A, Kanneganti TD (2020a) Identification of the PANoptosome: a molecular platform triggering pyroptosis, apoptosis, and necroptosis (PANoptosis). Front Cell Infect Microbiol 10:237. https://doi.org/10.3389/fcimb.2020.00237
Christgen S, Zheng M, Kesavardhana S, Karki R, Malireddi RKS, Banoth B, Place DE, Briard B, Sharma BR, Tuladhar S, Samir P, Burton A, Kanneganti TD (2020b) Identification of the PANoptosome: a molecular platform triggering pyroptosis, apoptosis, and necroptosis (PANoptosis). Front Cell Infect Microbiol. https://doi.org/10.3389/fcimb.2020.00237
Christgen S, Tweedell RE, Kanneganti TD (2022) Programming inflammatory cell death for therapy. Pharmacol Ther 232:108010. https://doi.org/10.1016/j.pharmthera.2021.108010
Dillon CP, Oberst A, Weinlich R, Janke LJ, Kang TB, Ben-Moshe T, Mak TW, Wallach D, Green DR (2012) Survival function of the FADD-CASPASE-8-cFLIP(L) complex. Cell Rep 1:401–407. https://doi.org/10.1016/j.celrep.2012.03.010
Dillon CP, Weinlich R, Rodriguez DA, Cripps JG, Quarato G, Gurung P, Verbist KC, Brewer TL, Llambi F, Gong YN, Janke LJ, Kelliher MA, Kanneganti TD, Green DR (2014) RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157:1189–1202. https://doi.org/10.1016/j.cell.2014.04.018
Du G, Healy LB, David L, Walker C, El-Baba TJ, Lutomski CA, Goh B, Gu B, Pi X, Devant P, Fontana P, Dong Y, Ma X, Miao R, Balasubramanian A, Puthenveetil R, Banerjee A, Luo HR, Kagan JC, Oh SF, Robinson CV, Lieberman J, Wu H (2024) ROS-dependent S-palmitoylation activates cleaved and intact gasdermin D. Nature 630:437–446. https://doi.org/10.1038/s41586-024-07373-5
Einhorn S, Grander D (1996) Why do so many cancer patients fail to respond to interferon therapy? J Interferon Cytokine Res 16:275–281. https://doi.org/10.1089/jir.1996.16.275
Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495–516. https://doi.org/10.1080/01926230701320337
Frank D, Vince JE (2019) Pyroptosis versus necroptosis: similarities, differences, and crosstalk. Cell Death Differ 26:99–114. https://doi.org/10.1038/s41418-018-0212-6
Fritsch M, Gunther SD, Schwarzer R, Albert MC, Schorn F, Werthenbach JP, Schiffmann LM, Stair N, Stocks H, Seeger JM, Lamkanfi M, Kronke M, Pasparakis M, Kashkar H (2019) Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature 575:683–687. https://doi.org/10.1038/s41586-019-1770-6
Gross CJ, Mishra R, Schneider KS, Medard G, Wettmarshausen J, Dittlein DC, Shi H, Gorka O, Koenig PA, Fromm S, Magnani G, Cikovic T, Hartjes L, Smollich J, AaB R, Cooper MA, Schmidt-Supprian M, Schuster M, Schroder K, Broz P, Traidl-Hoffmann C, Beutler B, Kuster B, Ruland J, Schneider S, Perocchi F, Gross O (2016) K(+) efflux-independent NLRP3 inflammasome activation by small molecules targeting mitochondria. Immunity 45:761–773. https://doi.org/10.1016/j.immuni.2016.08.010
Gurung P, Anand PK, Malireddi RK, Vande Walle L, Van Opdenbosch N, Dillon CP, Weinlich R, Green DR, Lamkanfi M, Kanneganti TD (2014) FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes. J Immunol 192:1835–1846. https://doi.org/10.4049/jimmunol.1302839
Gurung P, Burton A, Kanneganti TD (2016) NLRP3 inflammasome plays a redundant role with caspase 8 to promote IL-1beta-mediated osteomyelitis. Proc Natl Acad Sci U S A 113:4452–4457. https://doi.org/10.1073/pnas.1601636113
Han JH, Tweedell RE, Kanneganti TD (2023) Evaluation of caspase activation to assess innate immune cell death. J vis Exp. https://doi.org/10.3791/64308
Han JH, Karki R, Malireddi RKS, Mall R, Sarkar R, Sharma BR, Klein J, Berns H, Pisharath H, Pruett-Miller SM, Bae SJ, Kanneganti TD (2024) NINJ1 mediates inflammatory cell death, PANoptosis, and lethality during infection conditions and heat stress. Nat Commun 15:1739. https://doi.org/10.1038/s41467-024-45466-x
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674. https://doi.org/10.1016/j.cell.2011.02.013
He WT, Wan H, Hu L, Chen P, Wang X, Huang Z, Yang ZH, Zhong CQ, Han J (2015) Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion. Cell Res 25:1285–1298. https://doi.org/10.1038/cr.2015.139
Hubbard NW, Ames JM, Maurano M, Chu LH, Somfleth KY, Gokhale NS, Werner M, Snyder JM, Lichauco K, Savan R, Stetson DB, Oberst A (2022) ADAR1 mutation causes ZBP1-dependent immunopathology. Nature 607:769–775. https://doi.org/10.1038/s41586-022-04896-7
Jiao H, Wachsmuth L, Wolf S, Lohmann J, Nagata M, Kaya GG, Oikonomou N, Kondylis V, Rogg M, Diebold M, Troder SE, Zevnik B, Prinz M, Schell C, Young GR, Kassiotis G, Pasparakis M (2022) ADAR1 averts fatal type I interferon induction by ZBP1. Nature 607:776–783. https://doi.org/10.1038/s41586-022-04878-9
Kaiser WJ, Upton JW, Long AB, Livingston-Rosanoff D, Daley-Bauer LP, Hakem R, Caspary T, Mocarski ES (2011) RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471:368–372. https://doi.org/10.1038/nature09857
Kaiser WJ, Sridharan H, Huang C, Mandal P, Upton JW, Gough PJ, Sehon CA, Marquis RW, Bertin J, Mocarski ES (2013) Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem 288:31268–31279. https://doi.org/10.1074/jbc.M113.462341
Kang S, Fernandes-Alnemri T, Rogers C, Mayes L, Wang Y, Dillon C, Roback L, Kaiser W, Oberst A, Sagara J, Fitzgerald KA, Green DR, Zhang J, Mocarski ES, Alnemri ES (2015) Caspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3. Nat Commun 6:7515. https://doi.org/10.1038/ncomms8515
Karki R, Kanneganti TD (2021) The ‘cytokine storm’: molecular mechanisms and therapeutic prospects. Trends Immunol 42:681–705. https://doi.org/10.1016/j.it.2021.06.001
Karki R, Kanneganti TD (2023a) ADAR1 and ZBP1 in innate immunity, cell death, and disease. Trends Immunol 44:201–216. https://doi.org/10.1016/j.it.2023.01.001
Karki R, Kanneganti TD (2023b) PANoptosome signaling and therapeutic implications in infection: central role for ZBP1 to activate the inflammasome and PANoptosis. Curr Opin Immunol 83:102348. https://doi.org/10.1016/j.coi.2023.102348
Karki R, Sharma BR, Lee E, Banoth B, Malireddi RKS, Samir P, Tuladhar S, Mummareddy H, Burton AR, Vogel P, Kanneganti TD (2020) Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer. JCI Insight. https://doi.org/10.1172/jci.insight.136720
Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, Zheng M, Sundaram B, Banoth B, Malireddi RKS, Schreiner P, Neale G, Vogel P, Webby R, Jonsson CB, Kanneganti TD (2021a) Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell 184(149–168):e117. https://doi.org/10.1016/j.cell.2020.11.025
Karki R, Sundaram B, Sharma BR, Lee S, Malireddi RKS, Nguyen LN, Christgen S, Zheng M, Wang Y, Samir P, Neale G, Vogel P, Kanneganti TD (2021b) ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis. Cell Rep 37:109858. https://doi.org/10.1016/j.celrep.2021.109858
Karki R, Lee S, Mall R, Pandian N, Wang Y, Sharma BR, Malireddi RS, Yang D, Trifkovic S, Steele JA, Connelly JP, Vishwanath G, Sasikala M, Reddy DN, Vogel P, Pruett-Miller SM, Webby R, Jonsson CB, Kanneganti TD (2022) ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection. Sci Immunol 7:6294. https://doi.org/10.1126/sciimmunol.abo6294
Kayagaki N, Stowe IB, Lee BL, O’rourke K, Anderson K, Warming S, Cuellar T, Haley B, Roose-Girma M, Phung QT, Liu PS, Lill JR, Li H, Wu J, Kummerfeld S, Zhang J, Lee WP, Snipas SJ, Salvesen GS, Morris LX, Fitzgerald L, Zhang Y, Bertram EM, Goodnow CC, Dixit VM (2015) Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526:666–671. https://doi.org/10.1038/nature15541
Kesavardhana S, Kuriakose T, Guy CS, Samir P, Malireddi RKS, Mishra A, Kanneganti TD (2017) ZBP1/DAI ubiquitination and sensing of influenza vRNPs activate programmed cell death. J Exp Med 214:2217–2229. https://doi.org/10.1084/jem.20170550
Kim SB (2022) Function and therapeutic development of exosomes for cancer therapy. Arch Pharm Res 45:295–308. https://doi.org/10.1007/s12272-022-01387-1
Kitur K, Parker D, Nieto P, Ahn DS, Cohen TS, Chung S, Wachtel S, Bueno S, Prince A (2015) Toxin-induced necroptosis is a major mechanism of Staphylococcus aureus lung damage. PLoS Pathog 11:e1004820. https://doi.org/10.1371/journal.ppat.1004820
Lee S, Karki R, Wang Y, Nguyen LN, Kalathur RC, Kanneganti TD (2021) AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence. Nature 597:415–419. https://doi.org/10.1038/s41586-021-03875-8
Lee E, Song CH, Bae SJ, Ha KT, Karki R (2023) Regulated cell death pathways and their roles in homeostasis, infection, inflammation, and tumorigenesis. Exp Mol Med 55:1632–1643. https://doi.org/10.1038/s12276-023-01069-y
Li P, Zhou L, Zhao T, Liu X, Zhang P, Liu Y, Zheng X, Li Q (2017) Caspase-9: structure, mechanisms and clinical application. Oncotarget 8:23996–24008. https://doi.org/10.18632/oncotarget.15098
Liu S, Joshi K, Zhang L, Li W, Mack R, Runde A, Hagen PA, Barton K, Breslin P, Ji HL, Kini AR, Wang Z, Zhang J (2024) Caspase 8 deletion causes infection/inflammation-induced bone marrow failure and MDS-like disease in mice. Cell Death Dis 15:278. https://doi.org/10.1038/s41419-024-06660-3
Lukens JR, Gurung P, Vogel P, Johnson GR, Carter RA, Mcgoldrick DJ, Bandi SR, Calabrese CR, Vande Walle L, Lamkanfi M, Kanneganti TD (2014) Dietary modulation of the microbiome affects autoinflammatory disease. Nature 516:246–249. https://doi.org/10.1038/nature13788
Maiti R, Patel B, Patel N, Patel M, Patel A, Dhanesha N (2023) Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities. Arch Pharm Res 46:361–388. https://doi.org/10.1007/s12272-023-01447-0
Malireddi RKS, Gurung P, Kesavardhana S, Samir P, Burton A, Mummareddy H, Vogel P, Pelletier S, Burgula S, Kanneganti TD (2020ba) Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity–independent pyroptosis, apoptosis, necroptosis, and inflammatory disease. J Exp Med. https://doi.org/10.1084/jem.20191644
Malireddi RKS, Gurung P, Kesavardhana S, Samir P, Burton A, Mummareddy H, Vogel P, Pelletier S, Burgula S, Kanneganti TD (2020b) Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity-independent pyroptosis, apoptosis, necroptosis, and inflammatory disease. J Exp Med. https://doi.org/10.1084/jem.20191644
Malireddi RKS, Karki R, Sundaram B, Kancharana B, Lee S, Samir P, Kanneganti TD (2021) Inflammatory cell death, PANoptosis, mediated by cytokines in diverse cancer lineages inhibits tumor growth. Immunohorizons 5:568–580. https://doi.org/10.4049/immunohorizons.2100059
Man SM, Hopkins LJ, Nugent E, Cox S, Gluck IM, Tourlomousis P, Wright JA, Cicuta P, Monie TP, Bryant CE (2014) Inflammasome activation causes dual recruitment of NLRC4 and NLRP3 to the same macromolecular complex. Proc Natl Acad Sci U S A 111:7403–7408. https://doi.org/10.1073/pnas.1402911111
Mifflin L, Ofengeim D, Yuan J (2020) Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target. Nat Rev Drug Discov 19:553–571. https://doi.org/10.1038/s41573-020-0071-y
Mohammad RM, Muqbil I, Lowe L, Yedjou C, Hsu HY, Lin LT, Siegelin MD, Fimognari C, Kumar NB, Dou QP, Yang H, Samadi AK, Russo GL, Spagnuolo C, Ray SK, Chakrabarti M, Morre JD, Coley HM, Honoki K, Fujii H, Georgakilas AG, Amedei A, Niccolai E, Amin A, Ashraf SS, Helferich WG, Yang X, Boosani CS, Guha G, Bhakta D, Ciriolo MR, Aquilano K, Chen S, Mohammed SI, Keith WN, Bilsland A, Halicka D, Nowsheen S, Azmi AS (2015) Broad targeting of resistance to apoptosis in cancer. Semin Cancer Biol 35(Suppl):S78–S103. https://doi.org/10.1016/j.semcancer.2015.03.001
Munoz-Planillo R, Kuffa P, Martinez-Colon G, Smith BL, Rajendiran TM, Nunez G (2013) K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38:1142–1153. https://doi.org/10.1016/j.immuni.2013.05.016
Murphy JM, Czabotar PE, Hildebrand JM, Lucet IS, Zhang JG, Alvarez-Diaz S, Lewis R, Lalaoui N, Metcalf D, Webb AI, Young SN, Varghese LN, Tannahill GM, Hatchell EC, Majewski IJ, Okamoto T, Dobson RC, Hilton DJ, Babon JJ, Nicola NA, Strasser A, Silke J, Alexander WS (2013) The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39:443–453. https://doi.org/10.1016/j.immuni.2013.06.018
Nailwal H, Chan FK (2019) Necroptosis in anti-viral inflammation. Cell Death Differ 26:4–13. https://doi.org/10.1038/s41418-018-0172-x
Orning P, Weng D, Starheim K, Ratner D, Best Z, Lee B, Brooks A, **a S, Wu H, Kelliher MA, Berger SB, Gough PJ, Bertin J, Proulx MM, Goguen JD, Kayagaki N, Fitzgerald KA, Lien E (2018) Pathogen blockade of TAK1 triggers caspase-8–dependent cleavage of gasdermin D and cell death. Science 362:1064–1069. https://doi.org/10.1126/science.aau2818
Park J, Lee GE, An HJ, Lee CJ, Cho ES, Kang HC, Lee JY, Lee HS, Choi JS, Kim DJ, Choi JS, Cho YY (2021a) Kaempferol sensitizes cell proliferation inhibition in oxaliplatin-resistant colon cancer cells. Arch Pharm Res 44:1091–1108. https://doi.org/10.1007/s12272-021-01358-y
Park SJ, Joo SH, Lee N, Jang WJ, Seo JH, Jeong CH (2021b) ACY-241, an HDAC6 inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by inducing autophagy. Arch Pharm Res 44:1062–1075. https://doi.org/10.1007/s12272-021-01359-x
Park EJ, Jun HW, Na IH, Lee HK, Yun J, Kim HS, Kim Y, Hong JT, Han SB (2022) CD48-expressing non-small-cell lung cancer cells are susceptible to natural killer cell-mediated cytotoxicity. Arch Pharm Res 45:1–10. https://doi.org/10.1007/s12272-021-01365-z
Park M, Kang KW, Kim JW (2023) The role and application of transcriptional repressors in cancer treatment. Arch Pharm Res 46:1–17. https://doi.org/10.1007/s12272-023-01427-4
Peng F, Liao M, Qin R, Zhu S, Peng C, Fu L, Chen Y, Han B (2022) Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target Ther 7:286. https://doi.org/10.1038/s41392-022-01110-y
Pierini R, Juruj C, Perret M, Jones CL, Mangeot P, Weiss DS, Henry T (2012) AIM2/ASC triggers caspase-8-dependent apoptosis in Francisella-infected caspase-1-deficient macrophages. Cell Death Differ 19:1709–1721. https://doi.org/10.1038/cdd.2012.51
Sagulenko V, Thygesen SJ, Sester DP, Idris A, Cridland JA, Vajjhala PR, Roberts TL, Schroder K, Vince JE, Hill JM, Silke J, Stacey KJ (2013) AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC. Cell Death Differ 20:1149–1160. https://doi.org/10.1038/cdd.2013.37
Sborgi L, Ruhl S, Mulvihill E, Pipercevic J, Heilig R, Stahlberg H, Farady CJ, Muller DJ, Broz P, Hiller S (2016) GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death. EMBO J 35:1766–1778. https://doi.org/10.15252/embj.201694696
Sharma BR, Karki R, Rajesh Y, Kanneganti TD (2023) Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANoptosome activation and inflammatory cell death (PANoptosis). J Biol Chem 299:105141. https://doi.org/10.1016/j.jbc.2023.105141
Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y, Cai T, Wang F, Shao F (2015) Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526:660–665. https://doi.org/10.1038/nature15514
Sun L, Wang H, Wang Z, He S, Chen S, Liao D, Wang L, Yan J, Liu W, Lei X, Wang X (2012) Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148:213–227. https://doi.org/10.1016/j.cell.2011.11.031
Sundaram B, Pandian N, Mall R, Wang Y, Sarkar R, Kim HJ, Malireddi RKS, Karki R, Janke LJ, Vogel P, Kanneganti TD (2023) NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs. Cell 186(2783–2801):e2720. https://doi.org/10.1016/j.cell.2023.05.005
Szczerba M, Johnson B, Acciai F, Gogerty C, Mccaughan M, Williams J, Kibler KV, Jacobs BL (2023) Canonical cellular stress granules are required for arsenite-induced necroptosis mediated by Z-DNA-binding protein 1. Sci Signal 16:0837. https://doi.org/10.1126/scisignal.abq0837
Taabazuing CY, Okondo MC, Bachovchin DA (2017) Pyroptosis and apoptosis pathways engage in bidirectional crosstalk in monocytes and macrophages. Cell Chem Biol 24(507–514):e504. https://doi.org/10.1016/j.chembiol.2017.03.009
Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G (2019) The molecular machinery of regulated cell death. Cell Res 29:347–364. https://doi.org/10.1038/s41422-019-0164-5
Taylor RC, Cullen SP, Martin SJ (2008) Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9:231–241. https://doi.org/10.1038/nrm2312
Tse KM, Takeuchi O (2023) Innate immune sensing of pathogens and its post-transcriptional regulations by RNA-binding proteins. Arch Pharm Res 46:65–77. https://doi.org/10.1007/s12272-023-01429-2
Tsuchiya K, Nakajima S, Hosojima S, Thi Nguyen D, Hattori T, Le Manh T, Hori O, Mahib MR, Yamaguchi Y, Miura M, Kinoshita T, Kushiyama H, Sakurai M, Shiroishi T, Suda T (2019) Caspase-1 initiates apoptosis in the absence of gasdermin D. Nat Commun 10:2091. https://doi.org/10.1038/s41467-019-09753-2
Tweedell RE, Kumar SP, Kanneganti TD (2023) Innate sensing pathways: Defining new innate immune and inflammatory cell death pathways has shaped translational applications. PLoS Biol 21:e3002022. https://doi.org/10.1371/journal.pbio.3002022
Van Opdenbosch N, Van Gorp H, Verdonckt M, Saavedra PHV, De Vasconcelos NM, Goncalves A, Vande Walle L, Demon D, Matusiak M, Van Hauwermeiren F, D’hont J, Hochepied T, Krautwald S, Kanneganti TD, Lamkanfi M (2017) Caspase-1 engagement and TLR-induced c-FLIP expression suppress ASC/caspase-8-dependent apoptosis by inflammasome sensors NLRP1b and NLRC4. Cell Rep 21:3427–3444. https://doi.org/10.1016/j.celrep.2017.11.088
Walter EJ, Hanna-Jumma S, Carraretto M, Forni L (2016) The pathophysiological basis and consequences of fever. Crit Care 20:200. https://doi.org/10.1186/s13054-016-1375-5
Wang Y, Kanneganti TD (2021) From pyroptosis, apoptosis and necroptosis to PANoptosis: a mechanistic compendium of programmed cell death pathways. Comput Struct Biotechnol J 19:4641–4657. https://doi.org/10.1016/j.csbj.2021.07.038
Wang Y, Gao W, Shi X, Ding J, Liu W, He H, Wang K, Shao F (2017) Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature 547:99–103. https://doi.org/10.1038/nature22393
Wang R, Li H, Wu J, Cai ZY, Li B, Ni H, Qiu X, Chen H, Liu W, Yang ZH, Liu M, Hu J, Liang Y, Lan P, Han J, Mo W (2020) Gut stem cell necroptosis by genome instability triggers bowel inflammation. Nature 580:386–390. https://doi.org/10.1038/s41586-020-2127-x
Wang Y, Pandian N, Han JH, Sundaram B, Lee S, Karki R, Guy CS, Kanneganti TD (2022) Single cell analysis of PANoptosome cell death complexes through an expansion microscopy method. Cell Mol Life Sci 79:531. https://doi.org/10.1007/s00018-022-04564-z
Wu YT, Tan HL, Huang Q, Sun XJ, Zhu X, Shen HM (2011) zVAD-induced necroptosis in L929 cells depends on autocrine production of TNFalpha mediated by the PKC-MAPKs-AP-1 pathway. Cell Death Differ 18:26–37. https://doi.org/10.1038/cdd.2010.72
Xu W, Che Y, Zhang Q, Huang H, Ding C, Wang Y, Wang G, Cao L, Hao H (2021) Apaf-1 pyroptosome senses mitochondrial permeability transition. Cell Metab 33(424–436):e410. https://doi.org/10.1016/j.cmet.2020.11.018
Yang T, Wang G, Zhang M, Hu X, Li Q, Yun F, **ng Y, Song X, Zhang H, Hu G, Qian Y (2023) Triggering endogenous Z-RNA sensing for anti-tumor therapy through ZBP1-dependent necroptosis. Cell Rep 42:113377. https://doi.org/10.1016/j.celrep.2023.113377
Yang Y, Zhang H, **ao X, Guo M (2024) PANoptosis features, a humanized NSG murine model of Sjogren’s syndrome. DNA Cell Biol. https://doi.org/10.1089/dna.2023.0374
Yuan F, Cai J, Wu J, Tang Y, Zhao K, Liang F, Li F, Yang X, He Z, Billiar TR, Wang H, Su L, Lu B (2022) Z-DNA binding protein 1 promotes heatstroke-induced cell death. Science 376:609–615. https://doi.org/10.1126/science.abg5251
Zhang W, Fan W, Guo J, Wang X (2022) Osmotic stress activates RIPK3/MLKL-mediated necroptosis by increasing cytosolic pH through a plasma membrane Na(+)/H(+) exchanger. Sci Signal 15:5881. https://doi.org/10.1126/scisignal.abn5881
Zhang N, Zhang J, Yang Y, Shan H, Hou S, Fang H, Ma M, Chen Z, Tan L, Xu D (2024) A palmitoylation-depalmitoylation relay spatiotemporally controls GSDMD activation in pyroptosis. Nat Cell Biol 26:757–769. https://doi.org/10.1038/s41556-024-01397-9
Zhao J, Jitkaew S, Cai Z, Choksi S, Li Q, Luo J, Liu ZG (2012) Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci U S A 109:5322–5327. https://doi.org/10.1073/pnas.1200012109
Zheng D, Liwinski T, Elinav E (2020a) Inflammasome activation and regulation: toward a better understanding of complex mechanisms. Cell Discov 6:36. https://doi.org/10.1038/s41421-020-0167-x
Zheng M, Karki R, Vogel P, Kanneganti TD (2020b) Caspase-6 is a key regulator of innate immunity, inflammasome activation, and host defense. Cell 181(674–687):e613. https://doi.org/10.1016/j.cell.2020.03.040
Acknowledgements
This work was supported by new faculty startup funds from Seoul National University (2023-0024 to R.K), and by a grant (RS-2023-00251395) from the National Research Foundation of Korea (NRF). This work was also supported by a NRF grant funded by the Korean government (MSIT) (RS-2024-00355169 to J.H.H), and by Woosuk University (to J.H.H).
Funding
Funding was provided by New faculty startup funds from Seoul National University (Grant No. 2023-0024), National Research Foundation of Korea (Grant No. RS-2023-00251395), Woosuk University, National Research Foundation of Korea (Grant No. RS-2024-00355169).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declared no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bae, H., Jang, Y., Karki, R. et al. Implications of inflammatory cell death-PANoptosis in health and disease. Arch. Pharm. Res. (2024). https://doi.org/10.1007/s12272-024-01506-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12272-024-01506-0